Skip to content
Benefits & EvidenceEvidence-Tiered

Apelin Benefits

What does Apelin actually do? We break down the evidence by tier — human data, animal studies, and in vitro research — with citations for every claim.

Quick Answer

Apelin primarily benefits the cardiovascular system by increasing cardiac contractility without raising oxygen demand, dilating blood vessels, and promoting diuresis. Preclinical and early clinical studies suggest potential applications in heart failure, pulmonary hypertension, and metabolic disorders. More research is needed to confirm these benefits.

→ Apelin Dosage→ Apelin Side Effects→ Full Apelin Profile

Evidence Tiers

HumanClinical or observational human dataAnimalPreclinical in vivo studiesIn VitroCell / tissue culture studies
Table of Contents

Mechanism of Action

Apelin binds to the APJ receptor, a G protein-coupled receptor. This interaction activates downstream signaling pathways that lead to increased intracellular calcium in cardiomyocytes, promoting contractility. In endothelial cells, apelin stimulates nitric oxide production, causing vasodilation. Apelin also influences fluid balance through its diuretic effects.

Human Evidence

Human2 findings

Improved cardiac output in heart failure patients

Intravenous apelin infusion has been shown to improve cardiac output and reduce peripheral resistance in patients with chronic heart failure in early clinical studies.

PubMed 20410647 (2010) ↗

Reduced pulmonary vascular resistance in PAH patients (MM07 analog)

The synthetic apelin analog MM07 reduced pulmonary vascular resistance in a Phase 1 study of patients with pulmonary arterial hypertension.

PubMed 30205525 (2019) ↗

Animal Studies

Animal3 findings

Increased cardiac contractility

Apelin increases cardiac contractility in animal models without increasing myocardial oxygen consumption, a desirable effect in heart failure.

PubMed 17251365 (2007) ↗

Vasodilation and reduced blood pressure

Apelin causes vasodilation and reduces blood pressure in animal models through nitric oxide-dependent mechanisms.

PubMed 17251365 (2007) ↗

Improved glucose metabolism

Apelin enhances insulin sensitivity and glucose uptake in skeletal muscle in animal studies.

PubMed 18448625 (2008) ↗

In Vitro Research

In Vitro2 findings
In vitro (cell culture) findings are the earliest stage of evidence. They indicate mechanism plausibility but cannot confirm human effects.

Stimulation of nitric oxide production in endothelial cells

Apelin stimulates nitric oxide production in endothelial cells in vitro, contributing to its vasodilatory effects.

PubMed 17251365 (2007) ↗

Activation of intracellular signaling pathways

Apelin activates various intracellular signaling pathways, including PLC and PKC, in cardiomyocytes and endothelial cells.

PubMed 17251365 (2007) ↗

What's Proven vs What's Still Unknown

✓ What the Evidence Supports

  • ✓Positive cardiac inotropy (increases contractility)
  • ✓Vasodilation (reduces blood pressure)
  • ✓Diuretic effects (promotes fluid excretion)

? Still Unknown or Unconfirmed

  • ?Long-term effects of apelin on cardiovascular outcomes
  • ?Optimal dosing and administration routes for different conditions
  • ?Efficacy of apelin analogs in large-scale clinical trials

Frequently Asked Questions

What are the main benefits of apelin?
The primary benefits of apelin are its positive inotropic effects (increased cardiac contractility), vasodilatory effects (reduced blood pressure), and diuretic effects (increased fluid excretion). It may also have metabolic benefits.
Has apelin been proven effective in humans?
Early clinical studies have shown that intravenous apelin can improve cardiac output in heart failure patients and reduce pulmonary vascular resistance in PAH patients, but more extensive research is needed.
How does apelin improve cardiac function?
Apelin increases cardiac contractility without raising myocardial oxygen demand, a highly desirable property in failing hearts. It also dilates blood vessels, reducing afterload.
Can apelin help with diabetes?
Animal studies suggest that apelin can enhance insulin sensitivity and glucose uptake in skeletal muscle, but more research is needed to determine its potential benefits in diabetes.
What is the role of the APJ receptor?
The APJ receptor is the receptor for apelin. It is a G protein-coupled receptor expressed in cardiomyocytes, vascular endothelium, and other tissues. Activation of the APJ receptor mediates the cardiovascular effects of apelin.

References

  1. 1
    Apelin and the cardiovascular system: therapeutic potential and clinical evidence(2014)PubMed ↗
  2. 2
    Apelin increases cardiac contractility via protein kinase C-dependent mechanisms(2007)PubMed ↗
  3. 3
    The apelin-APJ axis in cardiovascular disease: emerging therapeutic strategies(2018)PubMed ↗
  4. 4
    Vasodilatory actions of apelin: an emerging target for cardiovascular disease?(2008)PubMed ↗
  5. 5
    Apelin in heart failure: current knowledge and future perspectives.(2014)PubMed ↗

Last updated: 2026-02-19